New Horizons in Lung Transplantation

  • Pablo Gerardo Sanchez
  • Dustin M. Walters
  • Michael S. Mulligan


The quantity and quality of donors continue to limit the number of lung transplants performed every year. Approximately 300 patients expire or are removed from the lung waiting list because they became too sick to transplant. Aggressive donor management, expansion of donor selection criteria, use of donors after circulatory determination of death, and use of ex vivo lung perfusion (EVLP) to screen the unused donor pool for viable organs are some of the strategies that are currently in place to reduce this gap. The purpose of this report is to review the most recent clinical and research publications and to summarize their findings.


Donor management Donation after circulatory determination of death Ex vivo lung perfusion Lung transplantation 


  1. 1.
    Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Rossano JW, Stehlik J, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report—2015; Focus theme: early graft failure. J Heart Lung Transplant. 2015;34(10):1264–77.CrossRefPubMedGoogle Scholar
  2. 2.
    Valapour M, Skeans MA, Heubner BM, Smith JM, Hertz MI, Edwards LB, Cherikh WS, Callahan ER, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2013 Annual Data Report: lung. Am J Transplant. 2015;15(Suppl 2):1–28.CrossRefPubMedGoogle Scholar
  3. 3.
    Israni AK, Zaun DA, Rosendale JD, Snyder JJ, Kasiske BL. OPTN/SRTR 2013 Annual Data Report: deceased organ donation. Am J Transplant. 2015;15(Suppl 2):1–13.CrossRefPubMedGoogle Scholar
  4. 4.
    Klein AS, Klein AS, Messersmith EE, Ratner LE, Kochik R, Baliga PK, Ojo AO. Organ donation and utilization in the United States, 1999-2008. Am J Transplant. 2010;10(4 Pt 2):973–86.CrossRefPubMedGoogle Scholar
  5. 5.
    Ware LB, Wang Y, Fang X, Warnock M, Sakuma T, Hall TS, Matthay M. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet. 2002;360(9333):619–20.CrossRefPubMedGoogle Scholar
  6. 6.
    Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19(12):1199–204.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Cypel M, Levvey B, Van Raemdonck D, Erasmus M, Dark J, Love R, Mason D, Glanville AR, Chambers D, Edwards LB, Stehlik J, Hertz M, Whitson BA, Yusen RD, Puri V, Hopkins P, Snell G, Keshavjee S, International Society for Heart and Lung Transplantation. International Society for Heart and Lung Transplantation donation after circulatory death registry report. J Heart Lung Transplant. 2015;34(10):1278–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Wigfield CH, Love RB. Donation after cardiac death lung transplantation outcomes. Curr Opin Organ Transplant. 2011;16(5):462–8.CrossRefPubMedGoogle Scholar
  9. 9.
    De Vleeschauwer SI, Wauters S, Dupont LJ, Verleden SE, Willems-Widyastuti A, Vanaudenaerde BM, Verleden GM, Van Raemdonck DE. Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. J Heart Lung Transplant. 2011;30(9):975–81.CrossRefPubMedGoogle Scholar
  10. 10.
    Krutsinger D, Reed RM, Blevins A, Puri V, De Oliveira NC, Zych B, Bolukbas S, Van Raemdonck D, Snell GI, Eberlein M. Lung transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis. J Heart Lung Transplant. 2015;34(5):675–84.CrossRefPubMedGoogle Scholar
  11. 11.
    Angel LF, Levine DJ, Restrepo MI, Johnson S, Sako E, Carpenter A, Calhoon J, Cornell JE, Adams SG, Chisholm GB, Nespral J, Roberson A, Levine SM. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med. 2006;174(6):710–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Minambres E, Pérez-Villares JM, Chico-Fernández M, Zabalegui A, Dueñas-Jurado JM, Misis M, Mosteiro F, Rodriguez-Caravaca G, Coll E. Lung donor treatment protocol in brain dead-donors: a multicenter study. J Heart Lung Transplant. 2015;34(6):773–80.CrossRefPubMedGoogle Scholar
  13. 13.
    Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, Freeman RB, Port FK, Merion RM, Love RB, Busuttil RW, Delmonico FL. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant. 2002;2(8):701–11.CrossRefPubMedGoogle Scholar
  14. 14.
    Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, Munari M, Boifava S, Cornara G, Della Corte F, Vivaldi N, Malacarne P, Del Gaudio P, Livigni S, Zavala E, Filippini C, Martin EL, Donadio PP, Mastromauro I, Ranieri VM. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304(23):2620–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Hanna K, Seder CW, Weinberger JB, Sills PA, Hagan M, Janczyk RJ. Airway pressure release ventilation and successful lung donation. Arch Surg. 2011;146(3):325–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Avlonitis VS, Wigfield CH, Kirby JA, Dark JH. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant. 2005;5(4 Pt 1):684–93.CrossRefPubMedGoogle Scholar
  17. 17.
    Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, Delmonico FL, Rosengard BR. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation. 2003;75(4):482–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Minambres E, Rodrigo E, Ballesteros MA, Llorca J, Ruiz JC, Fernandez-Fresnedo G, Vallejo A, González-Cotorruelo J, Arias M. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation. Nephrol Dial Transplant. 2010;25(7):2352–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Mattner F, Kola A, Fischer S, Becker T, Haverich A, Simon A, Suerbaum S, Gastmeier P, Weissbrodt H, Strüber M. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection. 2008;36(3):207–12.CrossRefPubMedGoogle Scholar
  20. 20.
    Bolton JS, Padia SA, Borja MC, Becker P, Orens JB, Wiener C, Yang SC, Conte JV. The predictive value and inter-observer variability of donor chest radiograph interpretation in lung transplantation. Eur J Cardiothorac Surg. 2003;23(4):484–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Baldwin MR, Peterson ER, Easthausen I, Quintanilla I, Colago E, Sonett JR, D’Ovidio F, Costa J, Diamond JM, Christie JD, Arcasoy SM, Lederer DJ. Donor age and early graft failure after lung transplantation: a cohort study. Am J Transplant. 2013;13(10):2685–95.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, Lederer DJ, Cantu E, Kohl BA, Lama VN, Bhorade SM, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah AS, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Ware LB, Palmer SM, Christie JD, Lung Transplant Outcomes Group. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013;187(5):527–34.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Reyes KG, Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Guidelines for donor lung selection: time for revision? Ann Thorac Surg. 2010;89(6):1756–64; discussion 1764–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Bonser RS, Taylor R, Collett D, Thomas HL, Dark JH, Neuberger J, Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK). Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet. 2012;380(9843):747–55.CrossRefPubMedGoogle Scholar
  25. 25.
    Hennessy SA, Hranjec T, Emaminia A, Lapar DJ, Kozower BD, Kron IL, Jones DR, Lau CL. Geographic distance between donor and recipient does not influence outcomes after lung transplantation. Ann Thorac Surg. 2011;92(5):1847–53.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Bittle GJ, Sanchez PG, Kon ZN, Claire Watkins A, Rajagopal K, Pierson RN 3rd, Gammie JS, Griffith BP. The use of lung donors older than 55 years: a review of the United Network of Organ Sharing database. J Heart Lung Transplant. 2013;32(8):760–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Kang CH, Anraku M, Cypel M, Sato M, Yeung J, Gharib SA, Pierre AF, de Perrot M, Waddell TK, Liu M, Keshavjee S. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant. 2011;30(3):289–98.CrossRefPubMedGoogle Scholar
  28. 28.
    Cypel M, Levvey B, Van Raemdonck D, Erasmus M, Love R, Mason D, Glanville A, Stehlik J, Herz M, Whitson B, Puri V, Dark J, Hopkins P, Snell G, Keshavjee S. Favorable outcomes of donation after cardiac death in lung transplantation: a multicenter study. J Heart Lung Transplant. 2013;32(4 Suppl):S15.CrossRefGoogle Scholar
  29. 29.
    Gries CJ, White DB, Truog RD, Dubois J, Cosio CC, Dhanani S, Chan KM, Corris P, Dark J, Fulda G, Glazier AK, Higgins R, Love R, Mason DP, Nakagawa TA, Shapiro R, Shemie S, Tracy MF, Travaline JM, Valapour M, West L, Zaas D, Halpern SD, American Thoracic Society Health Policy Committee. An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death. Am J Respir Crit Care Med. 2013;188(1):103–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Bernat JL, D’Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, Rosenbaum SH, Devita MA, Gaston RS, Merion RM, Barr ML, Marks WH, Nathan H, O’connor K, Rudow DL, Leichtman AB, Schwab P, Ascher NL, Metzger RA, Mc Bride V, Graham W, Wagner D, Warren J, Delmonico FL. Report of a National Conference on Donation after cardiac death. Am J Transplant. 2006;6(2):281–91.CrossRefPubMedGoogle Scholar
  31. 31.
    Cypel M, Sato M, Yildirim E, Karolak W, Chen F, Yeung J, Boasquevisque C, Leist V, Singer LG, Yasufuku K, Deperrot M, Waddell TK, Keshavjee S, Pierre A. Initial experience with lung donation after cardiocirculatory death in Canada. J Heart Lung Transplant. 2009;28(8):753–8.CrossRefPubMedGoogle Scholar
  32. 32.
    De Oliveira NC, Osaki S, Maloney JD, Meyer KC, Kohmoto T, D’Alessandro AM, Love RB. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg. 2010;139(5):1306–15.CrossRefPubMedGoogle Scholar
  33. 33.
    Mason DP, Brown CR, Murthy SC, Vakil N, Lyon C, Budev MM, Pettersson GB. Growing single-center experience with lung transplantation using donation after cardiac death. Ann Thorac Surg. 2012;94(2):406–11; discussion 411–2.CrossRefPubMedGoogle Scholar
  34. 34.
    Puri V, Scavuzzo M, Guthrie T, Hachem R, Krupnick AS, Kreisel D, Patterson GA, Meyers BF. Lung transplantation and donation after cardiac death: a single center experience. Ann Thorac Surg. 2009;88(5):1609–14; discussion 1614–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Zych B, Popov AF, Amrani M, Bahrami T, Redmond KC, Krueger H, Carby M, Simon AR. Lungs from donation after circulatory death donors: an alternative source to brain-dead donors? Midterm results at a single institution. Eur J Cardiothorac Surg. 2012;42(3):542–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Van De Wauwer C, Verschuuren EA, van der Bij W, Nossent GD, Erasmus ME. The use of non-heart-beating lung donors category III can increase the donor pool. Eur J Cardiothorac Surg. 2011;39(6):e175–80; discussion e180.CrossRefGoogle Scholar
  37. 37.
    Levvey BJ, Harkess M, Hopkins P, Chambers D, Merry C, Glanville AR, Snell GI. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative. Am J Transplant. 2012;12(9):2406–13.CrossRefPubMedGoogle Scholar
  38. 38.
    Thomas HL, Thomas HL, Taylor R, Simon AR, Clark SC, Dunning J, Yonan N, Banner NR, Dark JH. Donation after circulatory death lung activity in the UK—100 transplants and counting. J Heart Lung Transplant. 2013;32(4 Suppl):S15.CrossRefGoogle Scholar
  39. 39.
    Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27(5):2893–4.PubMedGoogle Scholar
  40. 40.
    Sanchez-Fructuoso AI, Prats D, Torrente J, Pérez-Contín MJ, Fernández C, Alvarez J, Barrientos A. Renal transplantation from non-heart beating donors: a promising alternative to enlarge the donor pool. J Am Soc Nephrol. 2000;11(2):350–8.PubMedGoogle Scholar
  41. 41.
    Gamez P, Córdoba M, Ussetti P, Carreño MC, Alfageme F, Madrigal L, Nuñez JR, Calatayud J, Ramos M, Salas C, Varela A, Lung Transplant Group of the Puerta de Hierro Hospital. Lung transplantation from out-of-hospital non-heart-beating lung donors. one-year experience and results. J Heart Lung Transplant. 2005;24(8):1098–102.CrossRefPubMedGoogle Scholar
  42. 42.
    Greco R, Cordovilla G, Sanz E, Benito J, Criado A, Gonzalez M, De Miguel E. Warm ischemic time tolerance after ventilated non-heart-beating lung donation in piglets. Eur J Cardiothorac Surg. 1998;14(3):319–25.CrossRefPubMedGoogle Scholar
  43. 43.
    Carrel A, Lindbergh CA. The culture of whole organs. Science. 1935;81(2112):621–3.CrossRefPubMedGoogle Scholar
  44. 44.
    Steen S, Ingemansson R, Budrikis A, Bolys R, Roscher R, Sjöberg T. Successful transplantation of lungs topically cooled in the non-heart-beating donor for 6 hours. Ann Thorac Surg. 1997;63(2):345–51.CrossRefPubMedGoogle Scholar
  45. 45.
    Wierup P, Andersen C, Janciauskas D, Bolys R, Sjoberg T, Steen S. Bronchial healing, lung parenchymal histology, and blood gases one month after transplantation of lungs topically cooled for 2 hours in the non-heart-beating cadaver. J Heart Lung Transplant. 2000;19(3):270–6.CrossRefPubMedGoogle Scholar
  46. 46.
    Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357(9259):825–9.CrossRefPubMedGoogle Scholar
  47. 47.
    LaPar DJ, Rosenberger LH, Walters DM, Hedrick TL, Swenson BR, Young JS, Dossett LA, May AK, Sawyer RG. Severe traumatic head injury affects systemic cytokine expression. J Am Coll Surg. 2012;214(4):478–86; discussion 486–8.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Wauters S, Somers J, De Vleeschauwer S, Verbeken E, Verleden GM, van Loon J, Van Raemdonck DE. Evaluating lung injury at increasing time intervals in a murine brain death model. J Surg Res. 2013;183(1):419–26.CrossRefPubMedGoogle Scholar
  49. 49.
    Machuca TN, Cypel M. Ex vivo lung perfusion. J Thorac Dis. 2014;6(8):1054–62.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Lindstedt S, Eyjolfsson A, Koul B, Wierup P, Pierre L, Gustafsson R, Ingemansson R. How to recondition ex vivo initially rejected donor lungs for clinical transplantation: clinical experience from Lund University Hospital. J Transplant. 2011;2011:754383.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Warnecke G, Moradiellos J, Tudorache I, Kühn C, Avsar M, Wiegmann B, Sommer W, Ius F, Kunze C, Gottlieb J, Varela A, Haverich A. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet. 2012;380(9856):1851–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Becker S, Steinmeyer J, Avsar M, Höffler K, Salman J, Haverich A, Warnecke G, Ochs M, Schnapper A. Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours. Transpl Int. 2016;29(1):88–97.CrossRefPubMedGoogle Scholar
  53. 53.
    Roman M, Gjorgjimajkoska O, Neil D, Nair S, Colah S, Parmar J, Tsui S. Comparison between cellular and acellular perfusates for ex vivo lung perfusion in a porcine model. J Heart Lung Transplant. 2015;34(7):978–87.CrossRefPubMedGoogle Scholar
  54. 54.
    Machuca TN, Machuca TN, Mercier O, Collaud S, Linacre V, Krueger T, Azad S, Singer L, Yasufuku K, de Perrot M, Pierre A, Waddell TK, Keshavjee S, Cypel M. Outcomes of lung transplantation using donation after cardiac death donors: should we use ex vivo lung perfusion? J Heart Lung Transplant. 2014;33(4 Suppl):S272.CrossRefGoogle Scholar
  55. 55.
    Yamada T, Nakajima D, Sakamoto J, Chen F, Okamoto T, Ohsumi O, Fujinaga T, Shoji T, Sakai H, Bando T, Date H. Reconditioning of lungs with pulmonary edema in ex vivo lung perfusion circuit. J Heart Lung Transplant. 2011;30(4S):S144.CrossRefGoogle Scholar
  56. 56.
    Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, Anraku M, Sato M, Harwood S, Pierre A, Waddell TK, de Perrot M, Liu M, Keshavjee S. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2008;27(12):1319–25.CrossRefPubMedGoogle Scholar
  57. 57.
    Kondo T, Chen F, Ohsumi A, Hijiya K, Motoyama H, Sowa T, Ohata K, Takahashi M, Yamada T, Sato M, Aoyama A, Date H. beta2-Adrenoreceptor agonist inhalation during ex vivo lung perfusion attenuates lung injury. Ann Thorac Surg. 2015;100(2):480–6.CrossRefPubMedGoogle Scholar
  58. 58.
    McAuley DF, Curley GF, Hamid UI, Laffey JG, Abbott J, McKenna DH, Fang X, Matthay MA, Lee JW. Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol. 2014;306(9):L809–15.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Gennai S, Monsel A, Hao Q, Park J, Matthay MA, Lee JW. Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Transplant. 2015;15(9):2404–12.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Andreasson A, Karamanou DM, Perry JD, Perry A, Özalp F, Butt T, Morley KE, Walden HR, Clark SC, Prabhu M, Corris PA, Gould K, Fisher AJ, Dark JH. The effect of ex vivo lung perfusion on microbial load in human donor lungs. J Heart Lung Transplant. 2014;33(9):910–6.Google Scholar
  61. 61.
    Nakajima D, Cypel M, Bonato R, Machuca TN, Iskender I, Hashimoto K, Linacre V, Chen M, Coutinho R, Azad S, Martinu T, Waddell TK, Hwang DM, Husain S, Liu M, Keshavjee S. Ex vivo perfusion treatment of infection in human donor lungs. Am J Transplant. 2016;16(4):1229–37.CrossRefPubMedGoogle Scholar
  62. 62.
    Meers CM, Tsagkaropoulos S, Wauters S, Verbeken E, Vanaudenaerde B, Scheers H, Verleden GM, Van Raemdonck D. A model of ex vivo perfusion of porcine donor lungs injured by gastric aspiration: a step towards pretransplant reconditioning. J Surg Res. 2011;170(1):e159–67.CrossRefPubMedGoogle Scholar
  63. 63.
    Inci I, Hillinger S, Arni S, Kaplan T, Inci D, Weder W. Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation. J Surg Res. 2013;184(2):1143–9.CrossRefPubMedGoogle Scholar
  64. 64.
    Khalife-Hocquemiller T, Sage E, Dorfmuller P, Mussot S, Le Houérou D, Eddahibi S, Fadel E. Exogenous surfactant attenuates lung injury from gastric-acid aspiration during ex vivo reconditioning in pigs. Transplantation. 2014;97(4):413–8.CrossRefPubMedGoogle Scholar
  65. 65.
    Gazoni LM, Laubach VE, Mulloy DP, Bellizzi A, Unger EB, Linden J, Ellman PI, Lisle TC, Kron IL. Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg. 2008;135(1):156–65.CrossRefPubMedGoogle Scholar
  66. 66.
    Stone ML, Sharma AK, Mas VR, Gehrau RC, Mulloy DP, Zhao Y, Lau CL, Kron IL, Huerter ME, Laubach VE. Ex vivo perfusion with adenosine A2A receptor agonist enhances rehabilitation of murine donor lungs after circulatory death. Transplantation. 2015;99(12):2494–503.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Wagner CE, Pope NH, Charles EJ, Huerter ME, Sharma AK, Salmon MD, Carter BT, Stoler MH, Lau CL, Laubach VE, Kron IL. Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death. J Thorac Cardiovasc Surg. 2016;151(2):538–45.CrossRefPubMedGoogle Scholar
  68. 68.
    Martens A, Boada M, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck D, Schols D, Claes S, Neyrinck AP. Steroids can reduce warm ischemic reperfusion injury in a porcine DCD model with EVLP evaluation. Transpl Int. 2016;29(11):1237–46.CrossRefPubMedGoogle Scholar
  69. 69.
    Motoyama H, Chen F, Hijiya K, Kondo T, Ohsumi A, Yamada T, Sato M, Aoyama A, Bando T, Date H. Plasmin administration during ex vivo lung perfusion ameliorates lung ischemia-reperfusion injury. J Heart Lung Transplant. 2014;33(10):1093–9.CrossRefPubMedGoogle Scholar
  70. 70.
    Fischer S, Liu M, MacLean AA, de Perrot M, Ho M, Cardella JA, Zhang XM, Bai XH, Suga M, Imai Y, Keshavjee S. In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia-reperfusion injury and improves early posttransplant graft function in the rat. Hum Gene Ther. 2001;12(12):1513–26.CrossRefPubMedGoogle Scholar
  71. 71.
    Martins S, de Perrot M, Imai Y, Yamane M, Quadri SM, Segall L, Dutly A, Sakiyama S, Chaparro A, Davidson BL, Waddell TK, Liu M, Keshavjee S. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther. 2004;11(24):1786–96.CrossRefPubMedGoogle Scholar
  72. 72.
    Yeung JC, Wagnetz D, Cypel M, Rubacha M, Koike T, Chun YM, Hu J, Waddell TK, Hwang DM, Liu M, Keshavjee S. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther. 2012;20(6):1204–11.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Machuca TN, Hsin MK, Ott HC, Chen M, Hwang DM, Cypel M, Waddell TK, Keshavjee S. Injury-specific ex vivo treatment of the donor lung: pulmonary thrombolysis followed by successful lung transplantation. Am J Respir Crit Care Med. 2013;188(7):878–80.CrossRefPubMedGoogle Scholar
  74. 74.
    Inci I, Yamada Y, Hillinger S, Jungraithmayr W, Trinkwitz M, Weder W. Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system. Ann Thorac Surg. 2014;98(5):1837–8.CrossRefPubMedGoogle Scholar
  75. 75.
    Luc JG, Bozso SJ, Freed DH, Nagendran J. Successful repair of donation after circulatory death lungs with large pulmonary embolus using the lung organ care system for ex vivo thrombolysis and subsequent clinical transplantation. Transplantation. 2015;99(1):e1–2.CrossRefPubMedGoogle Scholar
  76. 76.
    Gilpin SE, Ott HC. Using nature’s platform to engineer bio-artificial lungs. Ann Am Thorac Soc. 2015;12(Suppl 1):S45–9.CrossRefPubMedGoogle Scholar
  77. 77.
    Schmack B, Weymann A, Mohite P, Garcia Saez D, Zych B, Sabashnikov A, Zeriouh M, Schamroth J, Koch A, Soresi S, Ananiadou O, De Robertis F, Karck M, Simon AR, Popov AF. Contemporary review of the organ care system in lung transplantation: potential advantages of a portable ex-vivo lung perfusion system. Expert Rev Med Devices. 2016;13(11):1035–41.CrossRefPubMedGoogle Scholar
  78. 78.
    Cannon RM, Brock GN, Garrison RN, Smith JW, Marvin MR, Franklin GA. To pump or not to pump: a comparison of machine perfusion vs cold storage for deceased donor kidney transplantation. J Am Coll Surg. 2013;216(4):625–33; discussion 633–4.CrossRefPubMedGoogle Scholar
  79. 79.
    Treckmann J, Moers C, Smits JM, Gallinat A, Maathuis MH, van Kasterop-Kutz M, Jochmans I, Homan van der Heide JJ, Squifflet JP, van Heurn E, Kirste GR, Rahmel A, Leuvenink HG, Pirenne J, Ploeg RJ, Paul A. Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int. 2011;24(6):548–54.CrossRefPubMedGoogle Scholar
  80. 80.
    Hsin MK, Iskender I, Nakajima D, Chen M, Kim H, dos Santos PR, Sakamoto J, Lee J, Hashimoto K, Harmantas C, Hwang D, Waddell T, Liu M, Keshavjee S, Cypel M. Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2016;35(1):130–6.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  • Pablo Gerardo Sanchez
    • 1
  • Dustin M. Walters
    • 2
  • Michael S. Mulligan
    • 3
  1. 1.Division of Cardiothoracic Surgery, Department of SurgeryUniversity of WashingtonSeattleUSA
  2. 2.Department of Thoracic and Cardiovascular SurgeryUniversity of VirginiaCharlottesvilleUSA
  3. 3.Department of SurgeryUniversity of WashingtonSeattleUSA

Personalised recommendations